Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of PARP (Poly ADP-ribose Polymerase) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of PARP (Poly ADP-ribose Polymerase) Inhibitorsmarket, defines the market attractiveness level of PARP (Poly ADP-ribose Polymerase) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of PARP (Poly ADP-ribose Polymerase) Inhibitors industry, describes the types of PARP (Poly ADP-ribose Polymerase) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global PARP (Poly ADP-ribose Polymerase) Inhibitors market and the development prospects and opportunities of PARP (Poly ADP-ribose Polymerase) Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global PARP (Poly ADP-ribose Polymerase) Inhibitors market in Chapter 13.
By Player:
AstraZeneca
Merck & Co
Pfizer
Tesaro
Clovis Oncology
By Type:
Lynparza
Zejula
Rubraca
Talzenna
Other
By End-User:
Ovarian Cancer
Breast Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 PARP (Poly ADP-ribose Polymerase) Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.2 United States PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.5 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.6 India PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
-
7.7 South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption (2017-2022)
8 Region and Country-wise PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.6 India PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast (2022-2028)
9 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lynparza Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Zejula Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rubraca Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Talzenna Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lynparza Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Zejula Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rubraca Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Talzenna Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
14.2 Merck & Co
-
14.2.1 Merck & Co Company Details
-
14.2.2 Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
14.4 Tesaro
-
14.4.1 Tesaro Company Details
-
14.4.2 Tesaro PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Tesaro PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
14.5 Clovis Oncology
-
14.5.1 Clovis Oncology Company Details
-
14.5.2 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of PARP (Poly ADP-ribose Polymerase) Inhibitors
-
Figure PARP (Poly ADP-ribose Polymerase) Inhibitors Picture
-
Table Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption by Country (2017-2022)
-
Figure United States PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lynparza Consumption and Growth Rate (2017-2022)
-
Figure Global Zejula Consumption and Growth Rate (2017-2022)
-
Figure Global Rubraca Consumption and Growth Rate (2017-2022)
-
Figure Global Talzenna Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Lynparza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Zejula Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rubraca Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Talzenna Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global PARP (Poly ADP-ribose Polymerase) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global PARP (Poly ADP-ribose Polymerase) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
Table Tesaro (Foundation Year, Company Profile and etc.)
-
Table Tesaro PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
Table Clovis Oncology (Foundation Year, Company Profile and etc.)
-
Table Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Service
-
